FFAR2 and breast carcinoma: Similarly, Yonezawa found that both GPR41 and GPR43 were expressed in breast cancer cell lines; while combining with SCFAs, they raised intracellular concentration of Ca2+ and activated the p38 MAPK pathway, thereby inhibiting cell proliferation (38) (Table 1).